Health Canada projecting $3-billion spending drop as multiple programs hang in limbo
Reduced spending is attributed to the federal government’s spending review and expiring funding for the national strategy for rare disease drugs, Canadian Drugs and Substances Strategy, and for home care and mental health.
Health Canada could see a drop in spending by just over $3-billion over the next three years if multiple programs—including the rare disease drug strategy and the Canadian Drugs and Substances Strategy—begun under the previous Liberal government are not renewed.
Get Today's Headlines Newsletter
Wake up to the day's top political and policy headlines. Weekday Mornings.
By entering your email address you consent to receive email from The Hill Times containing news, analysis, updates and offers. You may unsubscribe at any time. See our privacy policy
